Neurovalens: Funding, Investors & Team (Sep 2026)
Neurovalens provides cutting-edge solutions in the realms of neuroscience, bioscience, and neurophysiology. With backing from Invest NI through the EU's Investment for Growth and Jobs Programme, Neurovalens' project will focus on research and development over the coming year to enhance the company's competitiveness.
Neurovalens has raised $9.5M across 3 funding rounds on record, the most recent an undisclosed round announced in May 2026.
Neurovalens Company Profile and Key Stats
Latest funding round on record: May 2026.
Neurovalens Funding Rounds
1 of 3 rounds was announced without a disclosed amount and is excluded from the total.
Neurovalens raised $2.7M in an undisclosed round announced in Apr 2024.
1.3 years later, an undisclosed round of $6.8M was announced in Aug 2025.
9 months later, an undisclosed round was announced in May 2026 with no disclosed amount.
Neurovalens Founders and Leadership Team
Contact details for the Neurovalens team: 1 of 1 has an email address on file.
Start 14-day free trial →Neurovalens Funding Compared to Other Biotechnology Startups
Funded Startups Like Neurovalens in Biotechnology and Belfast
Companies Similar to Neurovalens
Alchemab is harnessing the naturally protective power of patient antibodies to keep people free of…
Biodexa Pharmaceuticals is an international specialty pharmaceutical company focused on oncology and other…
Concert Bio helps businesses create optimal microbial communities.
RQ Bio is a biotechnology company that develops long-acting monoclonal antibodies against seasonal influenza…
N4 Pharma is a drug reformulation company focused on developing and out licensing new versions of existing…
Laverock Therapeutics is working on developing a system for suppressing genes, which can be used to create…
Oak hill bio is a clinical-stage rare disease therapeutics company developing life-changing medicines.
IMU is a discovery engine mapping the immune system to advance precision medicine.
Mykor is a climate tech start-up. It decarbonizes the construction industry by manufacturing carbon-negative…
Voxmind's biometric confirmation and authentication platform that provides voice based biometrics that helps…
Five is a biometric payment services company that offers thumb recognition technology for safe transactions.
Scarlet Therapeutics is developing the novel red blood cell-based therapeutics (tRBCs) generation platform.
Neurovalens Funding FAQs
What does Neurovalens do?
Neurovalens provides cutting-edge solutions in the realms of neuroscience, bioscience, and neurophysiology. With backing from Invest NI through the EU's Investment for Growth and Jobs Programme, Neurovalens' project will focus on research and development over the coming year to enhance the company's competitiveness.
How much funding has Neurovalens raised?
Neurovalens has raised $9.5M across 3 rounds on record.
When did Neurovalens last raise funding?
Neurovalens' most recent funding round on record was announced in May 2026. The amount was not disclosed.
Who founded Neurovalens?
FundedIQ lists Jason Mckeown (Founder) at Neurovalens.
Where is Neurovalens headquartered?
Neurovalens is based in Belfast, Belfast, United Kingdom.
How many employees does Neurovalens have?
Neurovalens is in the 11-50 employee band.
About FundedIQ's Neurovalens Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Neurovalens is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.